Literature DB >> 8429213

Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor beta 1.

D Danielpour1.   

Abstract

Transforming growth factor beta s (TGF-beta s), a highly homologous family of 25 kDa dimers, function as both paracrine and autocrine growth modulators which relay a broad spectrum of critical biological functions. Although sensitive bioassays for TGF-beta s have been described, their interference by other growth modulators have limited their application. We have previously described a highly sensitive (20-50 pg/ml) and specific sandwich enzyme-linked immunosorbent assay (SELISA) for TGF-beta 1, based on use of rabbit anti-TGF-beta 1 as the capture antibody. Widespread use of this assay was limited by the availability of this rather low-titer antibody. This report describes improved TGF-beta 1 SELISAs with comparable sensitivities to the above assay based on available sources of commercial monoclonal and polyclonal antibodies. These newly developed SELISAs are the most sensitive, specific, precise and convenient methods for the quantitation of TGF-beta 1 in complex biological fluids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429213     DOI: 10.1016/0022-1759(93)90254-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  14 in total

1.  An antibody present in normal human serum inhibits the binding of cytokines to their receptors in an in vitro system.

Authors:  D E Mosedale; D J Grainger
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masatoshi Jinnin; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-beta 1 in PWM-stimulated PBMC and T cells.

Authors:  D Reinhold; U Bank; F Bühling; U Lendeckel; J Faust; K Neubert; S Ansorge
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  Defects in transforming growth factor-beta signaling cooperate with a Ras oncogene to cause rapid aneuploidy and malignant transformation of mouse keratinocytes.

Authors:  A Glick; N Popescu; V Alexander; H Ueno; E Bottinger; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Proteolytic enzymes activities in patients after myocardial infarction correlate with serum concentration of TGF-beta.

Authors:  B Czarkowska-P Czek; J Przybylski; A Marciniak; M Pawłowska; J Juskowa; B Foroncewicz; K Mucha
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

6.  Production of recombinant proteins in Chinese hamster ovary cells overexpressing the subtilisin-like proprotein converting enzyme furin.

Authors:  T A Ayoubi; S M Meulemans; A J Roebroek; W J Van de Ven
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

7.  Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.

Authors:  Thomas Schneider; Michael Sailer; Siegfried Ansorge; Raimund Firsching; Dirk Reinhold
Journal:  J Neurooncol       Date:  2006-04-14       Impact factor: 4.130

8.  Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice.

Authors:  K Sellheyer; J R Bickenbach; J A Rothnagel; D Bundman; M A Longley; T Krieg; N S Roche; A B Roberts; D R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

10.  Laminin and transforming growth factor beta-1 in children with vesicoureteric reflux.

Authors:  Anna Sabasiñska; Walentyna Zoch-Zwierz; Anna Wasilewska; Tadeusz Porowski
Journal:  Pediatr Nephrol       Date:  2008-02-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.